#CCTG SC32S survey study opens in Canada, collecting sociodemographic data from clinical trial participants to understand the feasibility of using a survey to gather information about trial participants’ backgrounds and everyday lives. buff.ly/TpK7veq

The #CCTG Annual Spring Meeting is only 6 weeks away! Don't forget that the request an invitation portal closes April 7 and online registration closes April 9. All meeting information is available on the Spring Meeting webpage buff.ly/3Mkm0Gw

#CCTG opens the SC30 study investigating the role of immunoglobulin and antibiotics on infections in patients with blood cancers. Researchers will compare different approaches to preventing infections in people with blood cancers with low antibody levels. buff.ly/vNmoyLl

#CCTG IND Program has launched the Early Clinical Trials Educational Series - Session 2 an Interactive Workshop on Design and Execution of Phase I Trials is coming March 20! JOIN US: buff.ly/Wm4IjV1

The #CCTG CO.21 trial results proved that an exercise program after surgery and chemotherapy, reduces the risk of recurrent or new cancer and improves survival, allowing patients to live longer and better lives.

This is fantastic news for patients the #CCTG CO.21 trial results have set the standard for non-medical interventions and proves the benefits of a structured exercise program as part of a follow up care.

Today is #WorldCancerDay and #CCTG supports our 2,100 network researchers across Canada conducting the #ClinicalTrials that have a direct impact on improving treatment option for cancer patients @WorldCancerDay #CancerResearch

VISION | Investigator Leadership Training | Canadian Cancer Trials Group The CCTG VISION - Investigator Leadership Training Program is a new education and mentorship course designed to enhance the leadership skills of the next generation of clinical trialists. The program…

Only a few days left to get your application in as the deadline is approaching for the #CCTG VISION investigator leadership mentoring and training program. www.ctg.queensu.ca/public/visio...

Apply now for the #CCTG #VISION leadership mentoring and training program, providing investigators the opportunity to enhance their leadership skills through interactive, expert-facilitated workshops. Find out how to apply > buff.ly/qEhoFIW

CCSC Technology International Holdings Limited Announces 1-for-10 Reverse Stock Split Effective January 23, 2026 CCSC Technology International Holdings (Nasdaq: CCTG) will implement a 1-for-10 reverse stock split of its ordinary shares effective when markets open on January 23, 2026. The company will continue trading under the symbol CCTG with a new CUSIP G1993R118. The reverse split was approved by shareholders and the board and is being effected primarily to maintain compliance with Nasdaq Marketplace Rule 5550(a)(2) regarding minimum bid price. Fractional shares will be rounded up to the next whole share and no fractional shares will be issued. The reverse split will reduce outstanding Class A shares from approximately 34,134,950 to 3,413,495 and Class B shares from approximately 5,000,000 to 500,000.

#CCTG CCSC Technology International Holdings Limited Announces 1-for-10 Reverse Stock Split Effective January 23, 2026

www.stocktitan.net/news/CCTG/ccsc-technolog...

The results of the BR.31 global phase III study, testing adjuvant durvalumab in patients with completely resected non–small cell lung cancer and led by #CCTG, were published in the Journal of Clinical Oncology. buff.ly/JDYY7h2

CCTG year in review: 2025 accomplishments and 2026 strategic priorities | Canadian Cancer Trials Group 2025 was marked by scientific excellence, operational achievement, and renewed national and international recognition of the Canadian Cancer Trials Group’s leadership in academically driven cancer…

#CCTG year in review, Dr Janet Dancey reflects on the groups 2025 accomplishments and 2026 strategic priorities noting the continued scientific excellence, operational achievement, and renewed national and international recognition of the Canadian Cancer Trials Group.

Applications are now being accepted for the #CCTG 2026-2027 New Investigator Cancer Trials Practicum - a training program that enables the best and brightest new Canadian oncology researchers to acquire training and experience in cancer clinical trial conduct. Find how to apply: buff.ly/pVU9ts3

CCSC Technology International Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2025 HONG KONG, Dec. 23, 2025/ PRNewswire/-- CCSC Technology International Holdings Limited, a Hong Kong- based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced its unaudited financial results for the first six months of fiscal year 2026 ended September 30, 2025..

#CCTG CCSC Technology International Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2025

www.stocktitan.net/news/CCTG/ccsc-technolog...

CCSC Technology International Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency CCSC Technology International Holdings (Nasdaq: CCTG) received a Nasdaq notification on December 17, 2025 that it is not in compliance with the $1.00 minimum bid price requirement after a 30-business-day review covering November 4, 2025 to December 16, 2025.Nasdaq has provided 180 calendar days—until June 15, 2026—to regain compliance by achieving a closing bid of at least $1.00 for a minimum of 10 consecutive business days. The Company’s Nasdaq listing is not affected at this time and its business operations remain unchanged. The Company said it will monitor the share price and may consider options, including a reverse share split, to regain compliance.

#CCTG CCSC Technology International Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

www.stocktitan.net/news/CCTG/ccsc-technolog...

Mark your Calendars! #CCTG is pleased to announce that the 2026 Annual Spring Meeting of Participants will be held April 24-26, 2026, at the Chelsea Hotel in Toronto. buff.ly/i4nddE9

CCTG Recognition Awards Nominations 2026 | Canadian Cancer Trials Group The Canadian Cancer Trials Group is seeking nominations for the 2026 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. We are…

The Canadian Cancer Trials Group #CCTG is seeking nominations for the 2026 Recognition Awards honouring individuals and teams who have contributed significantly to the mission and activities of the Group. #TrialsThatMatter www.ctg.queensu.ca/bulletin/cct...

The holiday season is upon us - here is a reminder of all the specific dates and closures that will effect #CCTG specimen collection and delivery. This applies to all centres who are participating in #CCTG led trials. buff.ly/aUuXQzq

The #CCTG Scientific Leadership selection task force have recently announced two new Frances Shepherd Award recipients, congratulations to Florencia Comelles and Claire Norman! Their recent CCTG research projects demonstrated excellence in clinical trial and translational research buff.ly/ISOepb4

#RemembranceDay - Today we remember and pay tribute to the Canadian armed forces members who have died in the line of duty. #CCTG honours everyone who continues to serve and who defend our values and freedoms. #LestWeForget

The Canadian cancer research conference #CCRC2025 is now a wrap and #CCTG had a number of poster presentations and an oral presentation on the Development of Patient Priorities in Cancer Research by Judy Needham! Find out more: buff.ly/PSMnJ4S

#CCTG and #CancerResearchInstitute announce the first patient enrolled in a new sub-study for the #IPROC ovarian cancer #immunotherapy platform trial - a new #immunotherapy combination and patient population, accelerating progress toward more effective ovarian cancer treatments. buff.ly/rQWkoeZ

November is #LungCancerAwareness Month and #CCTG is raising awareness about lung cancer, its risks, and current research. The BR38 trial is looking at targeted radiotherapy during #immunotherapy for metastatic non-small cell #lungcancer buff.ly/zDyZu8M

#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. www.ctg.queensu.ca/bulletin/cct...

Thanks to the #CCTG sites and #breastcancer patients who participated, making Canada one of the top 10 accruing countries globally. Showing that it is possible to have a temporary interruption of endocrine therapy to permit pregnancy. @cancersociety.bsky.social @ccsresearch.bsky.social

Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.

Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM www.nejm.org/doi/10.1056/...

The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > buff.ly/ybihH1Y

CCSC Technology International Holdings to Advance Construction of New Supply Chain Management Center in Central Europe CCSC Technology (Nasdaq: CCTG) announced that its Serbian subsidiary signed a design and build MOU with Konstruktor Group to advance construction of a new European supply chain management center in Merosina, Serbia. The partnership contemplates a turnkey design and construction engagement to support CCSC’s logistics and manufacturing infrastructure in Central Europe. The company said the collaboration will enable moving forward with design and construction phases, with construction estimated to begin in November 2025. Management expects the center to enhance operational efficiency and serve as a logistics and manufacturing hub for the company’s European presence.

#CCTG CCSC Technology International Holdings to Advance Construction of New Supply Chain Management Center in Central Europe

www.stocktitan.net/news/CCTG/ccsc-technolog...

#BreastCancerAwarenessMonth the #CCTG MAC30 trial is testing the addition of chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning #PinkRibbon, #BCAM buff.ly/ABW5gHI